Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford University's work on precision cancer medicine has received a significant boost after Cancer Research UK announced that it would give the existing Cancer Research UK Oxford Centre Major Centre status and increase funding for research in the city.

Oxford is one of the first to gain Major Centre status, receiving an extra £5 million from Cancer Research UK over two years. The Centre will act as a vital research hub for a network of similar centres, drawing together expertise, encouraging collaborative research, and bridging the gap between innovative laboratory work and benefits for patients.

The new Major Centre strategy will focus on translating Oxford’s world-leading science across a broad range of disciplines, and ensure its translation into the clinic. Benefits for patients will be at the heart of its activities, drawing together expertise from different fields, including those not traditionally involved in cancer research.

Priorities include the development of new immunotherapies and bringing together biologists, physicists, mathematicians and engineers to deliver new treatments. Investment will tie together advances in diagnostics, genomics, surgery, imaging, radiotherapy, and drug development to fulfil the Centre’s vision for precision medicine.

Oxford University's Professor Gillies McKenna, director of the Cancer Research UK Oxford Centre, said: 'We look forward to making the most of our role as a Major Centre and leader in cancer research in the UK. The new initiative will bring researchers and clinicians together in sustainable networks with longer term investment. This will allow us to combine the latest developments in radiotherapy and surgery with clinical trials of new drugs, providing the best evidence to guide cancer treatment and enhance cancer cure rates.'

Read the full story on the Oxford of University's news pages.

Listen to the story on BBC Radio Oxford. Coverage starts at 40:24.

Learn more about precision cancer medicine: Precision & Accuracy; A Way Forward in Cancer Medicine by Gillies McKenna.

In the BBC News: Cancer Research UK centres receive £15m boost.

Explore our cancer research.

Similar stories

New Cochrane evidence highlights uncertainty about the interventions used to prevent and treat loss of smell after COVID-19 infection

Cochrane ENT at the Nuffield Department of Surgical Sciences has published two systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell following COVID-19 infection.

Using artificial intelligence (AI) for safer CT imaging of blood vessels

Congratulations to Dr Regent Lee at the Nuffield Department of Surgical Sciences (NDS) who has been awarded a grant of £246,226 from Heart Research UK for his research project ‘Using artificial intelligence (AI) for safer CT imaging of blood vessels’.

Developing new ways to assess kidneys so transplants last for longer

With funding from Kidney Research UK, a team of researchers from the University of Oxford, the University of Nottingham and University College London will develop ways to assess donor kidneys and predict how well they will work after transplant.

Potential for radiotherapy and VTP multimodality therapy for prostate cancer

A recent collaborative study from the University of Oxford has investigated the potential benefit of a combined therapy approach to prostate cancer treatment, using radiotherapy and vascular targeted photodynamic therapy (VTP), which could lead to first-in-man early phase clinical trials.

Omair Shariq wins Best Clinical Paper at the American Association of Endocrine Surgeons 2021 Annual Meeting

Dr Omair Shariq, a DPhil student and clinical research fellow in the Nuffield Department of Surgical Sciences (NDS) and Oxford Centre for Diabetes Endocrinology and Metabolism (OCDEM), has received the 2021 Best Presentation for Clinical Research award during the 41st Annual Meeting of the American Association of Endocrine Surgeons (AAES), which was held virtually on 25-27 April 2021.

Artificial intelligence tool for streamlining pathology workflow

A multidisciplinary team, comprising Andrea Chatrian, Dr Richard Colling, Professor Clare Verrill, Professor Jens Rittscher and colleagues, develops an algorithm for automated requesting of additional investigation in diagnostically uncertain prostate biopsies.

Blog posts

My virtual work experience with NDS and NDORMS

Louise Tan, a Year 12 student from Ballyclare in County Antrim, Northern Ireland, recently attended the joint NDS and NDORMS Virtual Work Experience. In this guest blog, Louise reflects on her experience.

Celebrating women of NDS

To celebrate 100 years since women were admitted as full members of the University and on the occasion of International Women's Day, a group of inspirational women in the Nuffield Department of Surgical Sciences (NDS) reflect on their journeys, their place in Medical Sciences and their vision for the next 100 years.

The life of a research nurse: supporting the Oxford COVID-19 Vaccine Trial

Research nurses in the NHS are playing a crucial role in helping to trial new coronavirus treatments and vaccines. Three NDS research nurses stepped up to help with the fight against this new disease. Here Bhumika Patel shares her experience of working on the Oxford COVID-19 Vaccine Trial.

Why I became a Peer Supporter

The Peer Support Programme was developed in recognition of the essential role students play in supporting and encouraging one another on a day-to-day basis throughout their time at university. NDS’ own Helen Stark discusses her experience of becoming a Peer Supporter.

Racism under the microscope

As Black History Month gets underway in the UK, NDS Athena SWAN Coordinator Emily Hotine puts racism under the microscope.